Plasmodium falciparum non-synonymous Kelch13 mutations mediating artemisinin resistance in East Africa: A systematic review and meta-analysis: 2014–2024
Anthony Kapesa, Vito Baraka, Richard Mwaiswelo, Maria Zinga, Karol J Marwa, Eliningaya J Kweka, Erasmus Kamugisha · 2026
Read Plasmodium falciparum non-synonymous Kelch13 mutations mediating artemisinin resistance in East Africa: A systematic review and meta-analysis: 2014–2024 by Anthony Kapesa, Vito Baraka, Richard Mwaiswelo, Maria Zinga, Karol J Marwa, Eliningaya J Kweka, Erasmus Kamugisha (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354429.txt.
Description
Anthony Kapesa led a team of seven authors on this 2026 systematic review of malaria drug resistance in East Africa. They pooled studies from 2014 to 2024 on mutations in the parasite's Kelch13 gene, which blunt the front-line drug artemisinin, and on how those mutations affect treatment results.
Resistance-linked mutations proved significantly common, led by two named variants, and parasites without them responded far better to treatment. Kapesa calls for continued molecular surveillance and coordinated regional action to stop partial resistance spreading across the continent, where East Africa has repeatedly been the starting ground for drug failure.
Catalog record
| CREATOR | Anthony Kapesa, Vito Baraka, Richard Mwaiswelo, Maria Zinga, Karol J Marwa, Eliningaya J Kweka, Erasmus Kamugisha |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28044 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |